Supporting the production of pharmaceuticals in Africa.
作者信息
Dong Jicui, Mirza Zafar
机构信息
Essential Medicines and Health Products Department, World Health Organization, avenue Appia, 1211 Geneva, Switzerland .
出版信息
Bull World Health Organ. 2016 Jan 1;94(1):71-2. doi: 10.2471/BLT.15.163782. Epub 2015 Nov 26.
Abstract
摘要
相似文献
1
Supporting the production of pharmaceuticals in Africa.
Bull World Health Organ. 2016 Jan 1;94(1):71-2. doi: 10.2471/BLT.15.163782. Epub 2015 Nov 26.
2
Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
Res Social Adm Pharm. 2009 Sep;5(3):286-97. doi: 10.1016/j.sapharm.2008.08.001. Epub 2009 Feb 3.
3
Access to medicines is not the business of the pharma industry.
J Int Assoc Physicians AIDS Care (Chic). 2002 Winter;1(1):9-11; discussion 12-4. doi: 10.1177/154510970200100102.
4
Access to medicines report cards.
Nat Rev Drug Discov. 2016 Nov 29;15(12):811. doi: 10.1038/nrd.2016.260.
5
The Health Impact Fund: incentives for improving access to medicines.
Lancet. 2010 Jan 9;375(9709):166-9. doi: 10.1016/S0140-6736(09)61296-4.
6
Research on green supply chain coordination strategy for uncertain market demand.
Pak J Pharm Sci. 2015 Mar;28(2 Suppl):687-92.
7
Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
Seton Hall Law Rev. 2011;41(2):625-69.
8
Drug shortage crisis resolution.
J Pharm Pract. 2012 Dec;25(6):619-20. doi: 10.1177/0897190012460987.
9
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
Chic J Int Law. 2002 Spring;3(1):27-46.
10
Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Public Health. 2019 Aug;173:1-4. doi: 10.1016/j.puhe.2019.04.019. Epub 2019 Jun 13.
引用本文的文献
1
Decolonizing global health: Africa's pursuit of pharmaceutical sovereignty.
BMC Health Serv Res. 2025 Aug 1;25(1):1015. doi: 10.1186/s12913-025-13211-9.
2
Breaking Barriers: Strengthening Health Equity in Sub-Saharan Africa Through Improved Local Pharmaceutical Production.
Health Hum Rights. 2025 Jun;27(1):117-120.
3
Cost and availability of selected medicines after implementation of increased import verification fees.
BMC Health Serv Res. 2024 Jan 4;24(1):25. doi: 10.1186/s12913-023-10433-7.
4
The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda.
J Pharm Policy Pract. 2023 Mar 23;16(1):51. doi: 10.1186/s40545-023-00552-1.
5
Improving the availability of prescription drugs in Lebanon: a critical analysis of alternative policy options.
Health Res Policy Syst. 2022 Oct 8;20(1):106. doi: 10.1186/s12961-022-00921-3.
6
Stakeholders' Perspectives Regarding Supply Chain System of Pharmaceuticals and Vaccines in Pakistan: A Qualitative Study.
Healthcare (Basel). 2022 Sep 10;10(9):1738. doi: 10.3390/healthcare10091738.
7
Factors influencing COVID-19 testing: a qualitative study in Bhutan.
Glob Health Res Policy. 2022 Apr 2;7(1):10. doi: 10.1186/s41256-022-00241-7.
8
The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.
BMC Public Health. 2021 Mar 11;21(1):490. doi: 10.1186/s12889-021-10374-y.
9
Fostering local production of essential medicines in Nigeria.
Bull World Health Organ. 2020 Jul 1;98(7):507-508. doi: 10.2471/BLT.19.249508. Epub 2020 Jun 2.
10
Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics.
Lancet. 2020 May 30;395(10238):1735-1738. doi: 10.1016/S0140-6736(20)31093-X. Epub 2020 May 7.
本文引用的文献
1
Commodities for better health in Africa--time to invest locally.
Bull World Health Organ. 2014 Jun 1;92(6):387-387A. doi: 10.2471/BLT.14.140566.
Zotero 插件